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We have introduced a mouse Thy-1.1 gene into 
the  germline of Thy-1.2  mice. The  introduced  gene 
was  shown to be expressed at very  high levels in 
thymocytes when compared with the endogenous 
gene.  Transgenic  thymocytes  were  shown to evoke 
a higher  than  normal  primary anti-Thy-l . 1 antibody 
response in plaque-forming cell (PFC) assays. This 
result suggests that  a  direct  quantitative  interaction 
of the Thy-1  antigen activates the B cell  response. 
The Thy- 1 antigen is a single  domain glyocprotein that 
is homologous to  the basic structural domain of the im- 
munoglobulin (Ig) superfamily of genes (1). Thy-1 has 
been most extensively  studied  on the cell surface of lym- 
phocytes, although it is expressed in several different 
tissues during development (2). most notably at high 
levels in  nerve  tissue of all  vertebrates (3,4). The expres- 
sion of Thy-  1  on the cell surface  varies between  different 
species: for example, mouse and rat thymocytes have 
abundant  Thy-  1,  but only a small  percentage of human 
thymocytes are positive (5). In contrast,  the  human  thy- 
mus  contains Thy-1 positive epithelial cells that induce 
thymocyte  differentiation (6). Such  patterns of distribu- 
tion and  the homology with the Ig superfamily clearly 
suggest that Thy-1 is involved in specific cell recognition 
even  though its specific  function is not known. In mice, 
the  Thy- 1 molecule contains 1 12  amino  acids  after p oc- 
essing  with  three  branches of N-linked carbohydrates (3). 
It has two allelic forms: Thy-1.1 and Thy-1.2, which 
differ by a single amino acid at position 89: Arg (Thy- 1.1) 
to Gln (Thy-1.2) (2, 3). This difference is sufficient to 
generate  a  strong allo-antibody response (7) and provides 
a good  model to  study allo-antibody response  against cell 
surface antigens. To facilitate such studies, strains of 
mice have been bred that  are congenic at  the Thy-  1 locus. 
These  strains  are identical  to all known  genetic loci ex- 
cept the Thy-1  locus,  although it is very difficult to ex- 
clude  other  differences at unknown loci. A different ap- 
proach  to produce congenic strains  has become available 
since  the development of successful  methods  to  introduce 
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foreign genes  into the germline of mice (8, 9). To study 
the regulated expression of the Thy-1 gene and  the  anti- 
Thy-1 allo-antibody response at  the molecular level, we 
describe in this report the introduction of the murine 
Thy-  1.1  gene  into fertilized eggs of Thy-  1.2  bearing mice. 
We show that  the introduced gene is expressed in the 
transgenic mice, and  the  transgenic Thy-  1.1  /Thy-  1.2 
thymocytes evoke a strong anti-Thy-1.1 antibody re- 
sponse  in  Thy-1.2 mice. 
MATERIALS AND METHODS 
Animals. C57BL/10 (BlO), CBA/J (CBA). AKR/J (AKR). (CBA/J X 
C57BL/10)F1. and (CBA X BIO)F1 mice were bred in the animal 
Breeding Laboratory, National Institute  for Medical Research, Mill 
Hill or were  supplied by the Imperial Cancer  Research  Fund, London. 
and  the  human Thy-1  gene,  which were  both cloned in the vector 
Constructfon of hybrid gene. The mouse genomic Thy- 1.1 gene 
PBSV (10, 11) were each restricted with PvuI x ApaI restriction 
enzymes  and were ligated by T4 DNA ligase. After transformation 
of HB101, plasmids. which contained the 5' end of the mouse 
genomic  Thy-1 . 1 gene  and  the 3' end of the  human Thy-1 gene, 
were  selected (Fig. 1). 
Transgenfc mfce. The mouse/human Thy-1 hybrid gene (H-M- 
Thy-1)  was removed from  the vector by a n  EcoRI restriction digest. 
The 9 kb M-H-Thy fragment was purified and  was microinjected 
preferably into the male pronucleus of fertilized eggs of (CBA x 
BIO)F1 mice. The injected eggs were implanted  into  the oviducts of 
pseudopregnant (CBA x BIO)F1 mice (9). After birth  and weaning, 
the pups were analyzed for the presence of the injected DNA by 
Southern blot analyses  (1  4) of tail DNA. Transgenic mice were bred 
to  expand  the population. The mice used  in this  analysis were  4-wk- 
old Fz mice. 
Southern blotting. Mouse tissue DNA was digested to completion 
by restriction enzymes  and  was electrophoresed on a 0.8% agarose 
gel. After denaturation  and  neutralization,  the DNA was  transferred 
to a nitrocellulose filter by Southern blotting (12).  The filter was 
hybridized with a 3ZP-labeled SacI-NcoI fragment, which was cut 
from  the 3' end of the  human Thy-1  gene (Fig. 2 )  and  was processed 
as described ( 10). 
dioimmune assays. Mouse monoclonal anti-Thy-1.1 antibody HO- 
Monoclonal antibody, indirect immunofluorescence, and ra- 
22.1 and anti-Thy 1.2 antibody HO-13.4 (13) were obtained from 
bated with 50 pl of 1/10 dilution  (minimal essential medium (MEM) 
hybridoma culture  supernatants. Target cells (1 X lo6) were incu- 
containing  0.1% NaAz + 5% fetal calf serum; FCS) of monoclonal 
antibody for 30 min at  4°C. After three  washings by MEM with 5% 
FCS and 0.1 % NaAz. cells  were resuspended in 50 p1 of 1/20 dilution 
of fluorescein isothiocyanate (F1TC)-rabbit anti-mouse Ig (Nordic 
Immunology, Tilburg, The  Netherlands). After three  washings,  the 
stained cells  were  examined under a fluorescence microscope. For 
radioimmune assays, '*'I-sheep anti-mouse Ig was used as the sec- 
ond antibody (Nordic Immunology). Absorption assays were per- 
formed as described in Figure 4. 
mocytes, brain  and  spleen cells  from AKR or transgenic mice were 
In vitro plaque-forming cell (PFCJ response. Suspensions of thy- 
suspended  in Eagle's MEM, and were  frozen and  thawed  three times. 
Thy-1.1 antigens were  cultured with  spleen cells of Thy-1.2-derived 
mice by a modified Mishell and Dutton technique  (14) by using a flat 
24-well plate. 
RPMI 1640 medium containing  10% FCS, 10 mM HEPES. and 5 x 
The Thy- 1.1 spleens  (1 0' viable  cells)  were suspended  in 1 ml of 
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Flgure I .  Structure of the  mouse-human  Thy- 1.1 gene. The  exons  and 
20).  The  translational  start codon is in  exon 11. which  codes  for the  signal 
contains  part of a transmembrane  sequence  and  the  translational  stop 
peptlde. Exon I11 codes for the extracellular Ig-like domain. Exon IV 
codon. The 3' end of the  mouse  gene  was  replaced  with  the 3' end of the 
human gene at the Apal [ A )  site, which leaves the Thy-1.1 protein 
structure  unchanged. S indicates Sac1 sites. 
I 2 3 4  
Drobe 
~ 
A p a  I Sac1 Ncol 
* I  
sac1 
" 
Mouse  Human 
Thy-1.1 Thy-1 
Figure 2. Southern blot analysis of Sac1 digested DNA from  transgenic 
mouse  T12. DNA [ 10 pg) from  different  tissues  was  electrophoresed  on 
agarose  gels,  was  blotted,  and  was hybrldized with a radloactlvity labeled 
NcoI x Sac1 restriction  fragment  corresponding  to  the 3' nd of the  human 
gene. lane 1.  (CBA X BIO)FI  thymus DNA: lane2.  T12  thymus DNA: lane 
3. T12  brain DNA: lane 4, T12  heart DNA. The  numbers  indicate  the 
position of a XxHinlII/EcoRI marker DNA. 
lo-' M 2-mercaptoethanol.  and  were  Incubated  at 37T In 5% COa- 
air. After 4 days,  direct (IgM) anti-Thy-1 PFC in  the  cultures  were 
determined as described by Fuji et al. (7). with  the use of AKR mouse 
thymocytes as a target  (1 5. 16). 
RESULTS 
Introduction of the  Thy-1.1  gene in  (Thy-1.21  mice. To 
be able to discriminate the injected Thy-1 .l  gene from 
the endogenous  Thy-1.2. we first modified the Thy-1.1 
gene. The non-coding last exon and 3' flanking se- 
quences were replaced with the corresponding  sequences 
of the  human Thy-1  gene at a common ApaI site,  which 
occurs a t  identical  positions in both genes  (10.  17).  This 
leaves all of the Thy- 1.1 antigen coding sequences  un- 
changed. The hybrid gene (M-H Thy-1) was isolated with- 
out vector sequences as  a 9 kb EcoRI restriction  fragment 
and  was injected into fertilized eggs of (CBA X BIO)FI 
mice. Of the  13 mice born,  four were found  to  contain 
the M-H Thy-1 gene (mice T6. T9, T11. and T12) by 
Southern blot analysis of tail DNA. Two of the mice (T6. 
T  12)  expressed the foreign Thy-  1  gene at very high levels, 
and  the  others expressed  it at lower levels. Mouse T12 
was used for the  results described below because  mouse 
T6 died before mating. Although tested  less  extensively, 
it should be pointed out that T6 show essentially the 
same  results as  mouse  T12. 
Southern  blots (Fig. 2) show a single  band  when the 
DNA from transgenic  mouse  T12  and  its  offspring are 
hybridized with  a probe that is isolated from the  human 
3' end of the introduced gene. Overexposures of the 
autoradiograph  also  show the endogenous mouse Thy-1 
gene. Together with a comparison of hybridization inten- 
sities of the introduced and endogenous  gene  with 5' end 
mouse Thy-1 probes (not shown), we conclude that  at 
least  40 copies of the injected gene  have  integrated. When 
several  different  restriction  enzymes  are used that cleave 
the Thy-1  gene  fragment only once, a single major band 
is observed,  which  indicates  a head to  tail configuration 
of 40 Thy-  1  genes in a  single  unique  integration  site. 
Expression of Thy-1.1 antigen in different tissues. 
To analyze the expression of the exogenous Thy- 1.1 and 
the endogenous  Thy-1.2  on the cell surface in different 
tissues of the  transgenic mice, cell suspensions of several 
tissue were examined by indirect immunofluorescence 
by using  anti-Thy- 1.1 (HO 22.1)  or  anti-Thy-  1.2 (HO 13.4) 
monoclonal antibodies as  the  first antibody, followed  by 
staining with an FITC-rabbit anti-mouse Ig. Thymocytes 
from the  transgenic  animal  stained brightly after binding 
both anti-Thy-1.1 and anti-Thy-1.2.  whereas the controls 
AKR J (Thy-1.1)  or F1 CBA (Thy-1.2) thymocytes are only 
stained  after  binding  anti-Thy-1.1  or  anti-Thy-1.2  anti- 
body, respectively (Fig. 3). The  same  pattern  was obtained 
for  brain  tissues,  whereas liver, kidney, and  heart 
showed no  detectable  fluorescence in any of the  animals 
(data not  shown). To quantitate  the  amount of Thy-1.1 
antigen  expressed on the  transgenic  tissues, absorption 
assays were carried  out.  Increasing numbers of cells from 
different  transgenic  tissues  and  control AKR (Thy-1.1) 
thymocytes were used to  absorb anti-Thy-l . 1 antibody 
(1/10 HO 22.1). The cells were pelleted, and  the remain- 
ing  antibody  in the  supernatant was plotted as a  function 
of increasing cell numbers (Fig. 4). The  result  shows  that 
the  transgenic thymocytes and  brain cells (50% absorp- 
tion at 3 to 5 X lo5 cells) expressed a high amount of 
Thy-1 . 1  antigen  on  the cell surface, 6 to 10 times higher 
than control AKR thymocytes (50% absorption at 3 x lo6 
cells). Transgenic liver, kidney, spleen,  and  heart  tissue 
were also  tested for absorption. Liver and spleen showed 
some  absorption (50% absorption at  3 to  7 x lo7 cells), 
d T H Y - 1 . 1  d T H Y - 1 . 2  - 
A K R I J  l!"-lfl 
Transgenic, AKRfJ. and CRA thymocytes were assayed with 0-Thy-1.1 
Ffgure3. Fluoresrencr antibody binding by transgenic thymocytes. 
and  a-Thy-1.2 a s  descrlbed  in  Materials and  Methods. No fluorescence 
is observed In a  control  staining  in  the  absence of anti  Thy-1  antibody. 
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TABLE 1 
I I I I I 
1 0 '  105 106 l o 7  IO* 
t e l l s  
Figure 4. Anti  Thy-1  antibody  absorption assay with the  use of var- 
ious transgenic mice tissues. Monoclonal anti-mouse Thy-1.1  antibody 
(100 pl diluted 1/10] (HO 22.1) was  absorbed with  various amounts of 
thymocytes (0) or brain (m, liver (0). spleen (+I, heart ($) , kidney (A) of 
transgenic mice and thymocytes (0) of AKR mice. After centrifugation, 
50 pl  of the  supernatant were  assayed in duplicate  for  residual  antibody 
activity by an incubation with  5 X lo6 AKR thymocytes as target.  This 
was followed by a second incubation with Iz5I-sheep anti-mouse Ig. The 
results are the mean of duplicate experiments  and  are plotted as the 
counts bound by residual  antibody in  the  supernatant  vs  the  number of
cells in the binding. 
which is probably caused by the presence of peripheral 
T cells in  these  tissues. Kidney and  heart were negative. 
The  same  tissues were analyzed by S1 nuclease protec- 
tion assays to assess  the  amounts of Thy- 1.1 and Thy- 
1.2 RNA. The  results  show  that  the  amount of Thy-  1 
antigen on the cell surface closely follows the levels of 
RNA transcription (Kollias and Spanopoulou). From these 
results, we conclude that  the introduced  Thy- 1.1 gene is 
expressed  in a correct  tissue-specific manner  and at least 
in  mouse  T 12  at 6 to 10  times  higher than normal levels 
due  to  increased  amounts of tissue specific transcription. 
Thymocytes of the  transgenic  mice  evoke a strong 
primary  anti-Thy-1.1  antibody  response  in  vitro. Thy- 
mocytes, brain and spleen  cells  from the  transgenic mice 
were used to induce a primary anti-Thy-l . 1 antibody 
response in a PFC in vitro. As might be expected from 
the quantitation  assays, the thymocytes from the Thy- 
1.1  transgenic mice evoked a very strong  primary anti- 
Thy-1 . 1 PFC response in CBA mice (Table I). This re- 
sponse was even stronger than  the high response ob- 
tained  with  normal AKR/J (Thy-  1.1)  thymocytes in CBA 
mice. A clear anti-Thy-l . 1 PFC response  was  obtained 
with only 100  transgenic thymocytes and peaked at lo5 
cells per well.  More than  2000 PFC per lo7 CBA spleen 
cells were obtained, which is 5 to 10 times the PFC 
obtained for lo5 AKR/J thymocytes per 10' CBA spleen 
cells. Thymocytes from (CBA X BIO)FI mice or C57BL/lO 
mice did not develop any primary  anti-Thy-  1.1 PFC re- 
sponse  in CBA mice. In agreement  with previous studies 
(1 6). brain cells from the transgenic mice induced a  much 
weaker  response,  although  higher than  that induced by 
AKR/J cells. Finally, spleen cells also evoked a weak 
response,  presumably  because there is only a low  level of 
Thy-1 . 1 antigen  (see Fig. 3). Interestingly, large numbers 
of brain cells or  spleen cells inhibited the  anti-Thy-1.1 
PFC response  in vitro for reasons  that we do not  under- 
stand. Although these  results  indicate  that  the primary 
PFC response evoked by the transgenic thymocytes is 
Thy-  1.1  specific,  they do not completely rule  out  a  con- 
Primary  anti-Thy-1  antibody  responses  induced by 
Thy-I. 1 transgenic  mkea 
209 1 
Source of 
Antigen Dose Transgenic 
Donor  mice/PFC  per  Well (SE) 
AKR CBAXB10  B10mice 
Thymocytes 10' 24  (4) 0 
lo' 548 (32) 0 
lo3 224  (16) 0 
lo5 2552 (58) 326 (161 0 0 
Brain lo4 188  (16) 0 
lo6 452  (150) 73 (8) 
1 o7 0 20 12) 
Spleen 103 2 (21 
106 44 12) 
lo5 88 (4) 
frozen and thawed thymocytes, brain and spleen cells from Thy-1.1 
a Spleen  cells (1 X 10' cells/well) from CBA mice were cultured  with 
transgenic mice, AKR/J mice, CBA x B10 mice, or B10 mice as described 
determined with the use of AKR/J mouse thymocytes as targets. PFC 
(1 8). After 4 days in culture, direct (IgM] anti Thy-1.1 PFC responses were 
values are  the  mean value of four wells of one  experiment. Additional 
experiments gave  essentially the  same result. 
TABLE I1 
Genetic control of primary  anti  Thy-1.1 PFC responses  evoked by 
Thy-I. 1 transgenic mice" 
Immunogen  Dose 
Recipient  StralnlPFC per Well (SE) 
CBA CBAXB10  B10 
Thymocytes (transgenic) lo3 120  (4)  138 ( 2) 4 (1 )  
lo5 1005 (33) 1113  (45)  44 (4) 
Brain (transgenic] lo3 94 (8) 98 (4) 0 
10" 250 (5) 202(14) 0 
Thymocytes (AKR/J) lo3 44 (3) 54 (3) 0 
lo5 146136)  116 1121 0 
Dose CBA BALBIc DBAIZ B10  BlOBR BDFl 
Thymocytes lo5 1,380  (72) 56 (4)  72  (7)  172  (13) 0 556  (29) 
For each  strain more than  15 mice were used as responders in separate 
a Spleen  cells  were taken from individual mice (age and sex matched). 
assays.  The PFC shown  here  are  representative of one mouse from each 
strain  (mean of four wells). The  other  14 PFC assays show  similar  values. 
In the lower part of the  table,  spleen cells were collected from three mice 
of each  strain. 
tribution from other  antigens. 
Genetic control of the  anti-Thy-1.1  antibody  re- 
sponse. Because the Thy- 1.1 transgenic mice were made 
from (CBA X BIO)F1 mice for technical  reasons  (1  1). the 
thymocytes of the transgenic mice will have  a  combina- 
tion of cell surface  antigens from CBlO and CBA. Some 
of these could possibly give a  response in the PFC assay 
with CBA spleen cells. To exclude this possibility and to 
confirm that  the response is Thy-1.1 specific, but de- 
pendent on other genetic loci, we measured the PFC 
response  to the  transgenic thymocytes by using 15 indi- 
vidual CB10, CBA, or (CBA X BIO)F1 mice. As  shown  in 
Table 11, CBA or (CBA x BIO)Fl mice developed more than 
1000 PFC per well in every case. In contrast, B10 mice 
responded poorly, indicating that certain IgH type strains 
are poor responders. This  was confirmed by using  several 
other mouse strains as responders (18), both B10 and 
DBA/2 mice responded poorly, whereas BDFl mice re- 
sponded well to transgenic  thymocytes  (Table 11). in  agree- 
ment with Zalesky et al. (19) who used conventional 
thymocytes. This  result  confirms that  the PFC response 
is anti-Thy-l . 1 specific and is not influenced by variation 
of the  other (CBA X B10) cell surface  markers. 
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DISCUSSION 
The  results from this  study  show that  the Thy-1  gene 
can be introduced  into the germ line of mice and  can give 
rise to animals  that  express  the exogenous Thy-1  gene in 
a  tissue specific manner.  This  shows  that  the regulatory 
sequences in cis on the 9 kb EcoRI fragment  are  suffi- 
cient to allow specific and efficient expression of the 
gene,  although the levels varied between different trans- 
genic mice. In the mice used in this study (T12), the 
(introduced)  Thy-1 . 1  antigen is expressed at 6 to 10 times 
the level of the Thy-  1.2  antigen (Fig. 3). This is probably 
caused by the large number of integrated  Thy-  1.1  genes, 
although we do not  know  whether  all of the genes,  or to 
what  extent individual genes, are expressed.  The  results 
show that  the high level of Thy- 1.1 expression results in 
a very strong specific anti-Thy-l . 1  primary  antibody  re- 
sponse by either CBA or (CBA X C57BL/10)FI mice. This 
response is much  stronger than  any previously observed 
primary anti-Thy-l . 1  antibody  responses, such as that 
obtained by AKR/J thymocytes and CBA spleen cells (1 8). 
Because the high level of the response is the  same in all 
of the tested (CBA X C57BL/10)F1 mice, it suggests that 
the Thy-1 antigen itself is directly responsible for the 
primary B cell activation.  Whether the  strong response is 
caused exclusively by the very high  quantity of Thy- 1 on 
the cell surface, or secondry structural changes that 
might occur as a  result of the high expression, is pres- 
ently not known.  Other T cell surface  antigens of the Ig 
superfamily that occur a t  a much lower level on the 
thymocyte cell surface  fail to give the primary  response. 
The possibility to  introduce  genes  into the germline of 
mice and to  express  different  amounts of any given cell 
surface  marker therefore  allows the  study of particular 
cell-cell interactions at  the molecular level. In the  case of 
the Thy-  1  antigen,  both the level of Thy-1  expression can 
be changed  without  changing  other  surface markers,  and 
more interestingly, the Thy-1 protein structure on the 
cell surface  can be modified by gene  manipulation. The 
latter possibility would allow a study of the  function of 
the Thy-  1  antigen  in vivo and  its function  in  the  primary 
B cell response  in  particular. 
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